Literature DB >> 29199136

Cerebral venous collaterals: A new fort for fighting ischemic stroke?

Lu-Sha Tong1, Zhen-Ni Guo2, Yi-Bo Ou3, Yan-Nan Yu4, Xiao-Cheng Zhang4, Jiping Tang5, John H Zhang6, Min Lou7.   

Abstract

Stroke therapy has entered a new era highlighted by the use of endovascular therapy in addition to intravenous thrombolysis. However, the efficacy of current therapeutic regimens might be reduced by their associated adverse events. For example, over-reperfusion and futile recanalization may lead to large infarct, brain swelling, hemorrhagic complication and neurological deterioration. The traditional pathophysiological understanding on ischemic stroke can hardly address these occurrences. Accumulating evidence suggests that a functional cerebral venous drainage, the major blood reservoir and drainage system in brain, may be as critical as arterial infusion for stroke evolution and clinical sequelae. Further exploration of the multi-faceted function of cerebral venous system may add new implications for stroke outcome prediction and future therapeutic decision-making. In this review, we emphasize the anatomical and functional characteristics of the cerebral venous system and illustrate its necessity in facilitating the arterial infusion and maintaining the cerebral perfusion in the pathological stroke content. We then summarize the recent critical clinical studies that underscore the associations between cerebral venous collateral and outcome of ischemic stroke with advanced imaging techniques. A novel three-level venous system classification is proposed to demonstrate the distinct characteristics of venous collaterals in the setting of ischemic stroke. Finally, we discuss the current directions for assessment of cerebral venous collaterals and provide future challenges and opportunities for therapeutic strategies in the light of these new concepts.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral venous collaterals; Cerebral venous system; Endovascular therapy; Ischemic stroke

Mesh:

Year:  2017        PMID: 29199136      PMCID: PMC6389333          DOI: 10.1016/j.pneurobio.2017.11.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  206 in total

1.  MR angiography of the intracranial venous system.

Authors:  L Liauw; M A van Buchem; A Spilt; F T de Bruïne; R van den Berg; J Hermans; M N Wasser
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

2.  High-resolution BOLD venographic imaging: a window into brain function.

Authors:  J R Reichenbach; E M Haacke
Journal:  NMR Biomed       Date:  2001 Nov-Dec       Impact factor: 4.044

3.  High-resolution blood oxygen-level dependent MR venography (HRBV): a new technique.

Authors:  J R Reichenbach; L Jonetz-Mentzel; C Fitzek; E M Haacke; D K Kido; B C Lee; W A Kaiser
Journal:  Neuroradiology       Date:  2001-05       Impact factor: 2.804

4.  Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.

Authors:  T Abumiya; R Fitridge; C Mazur; B R Copeland; J A Koziol; J F Tschopp; M D Pierschbacher; G J del Zoppo
Journal:  Stroke       Date:  2000-06       Impact factor: 7.914

Review 5.  Micronized purified flavonoid fraction and the treatment of chronic venous insufficiency: microcirculatory mechanisms.

Authors:  P D Smith
Journal:  Microcirculation       Date:  2000       Impact factor: 2.628

6.  A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease.

Authors:  G Danielsson; C Jungbeck; K Peterson; L Norgren
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-01       Impact factor: 7.069

7.  Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke.

Authors:  L S Ritter; J A Orozco; B M Coull; P F McDonagh; W I Rosenblum
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

8.  Activity of a sub-cutaneously administered novel mixed micellar formulation of argatroban in rat and rabbit models of venous thrombosis.

Authors:  C N Berry; C Visconte; C Lecoffre; S Lochot; D Girard
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

Review 9.  Consequences of the anatomy of deep venous outflow from the brain.

Authors:  J Andeweg
Journal:  Neuroradiology       Date:  1999-04       Impact factor: 2.804

10.  Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses.

Authors:  Ludmila Belayev; Elisabeth Pinard; Helene Nallet; Jacques Seylaz; Yitao Liu; Panomkhawn Riyamongkol; Weizhao Zhao; Raul Busto; Myron D Ginsberg
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

View more
  6 in total

1.  Investigating the role of susceptibility weighted imaging for assessment of ischemic penumbra with respect to Venus blood flow in ischemic stroke patients.

Authors:  Saeid Sadeghi Joni; Reza Gerami; Negin Akhondi; Ali Etemadi; Mahnaz Fosouli; Aynaz Foroughi Eghbal
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

2.  Filling Defect of Ipsilateral Transverse Sinus in Acute Large Artery Occlusion.

Authors:  Yi Chen; Sheng Zhang; Shenqiang Yan; Meixia Zhang; Ruiting Zhang; Feina Shi; David S Liebeskind; Mark Parsons; Min Lou
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

Review 3.  Integrative cerebral blood flow regulation in ischemic stroke.

Authors:  Jui-Lin Fan; Patrice Brassard; Caroline A Rickards; Ricardo C Nogueira; Nathalie Nasr; Fiona D McBryde; James P Fisher; Yu-Chieh Tzeng
Journal:  J Cereb Blood Flow Metab       Date:  2021-07-14       Impact factor: 6.960

4.  The Value of a Management Plan Based on Risk Factors for Cerebral Infarction Patients with Cerebral Hemorrhage.

Authors:  Jinfeng Dang; Jieting Li; Haixia Li; Gaoyan Pian; Zhizhuan Guo
Journal:  J Healthc Eng       Date:  2022-04-08       Impact factor: 3.822

5.  Predictive Factors for Early-Onset Seizures in Patients With Cerebral Venous Sinus Thrombosis.

Authors:  Shuwen Mu; Jun Li; Kunzhe Lin; Yi Fang; Feng Lin; Ziqi Li; Yongjun Xu; Shousen Wang
Journal:  Front Neurol       Date:  2022-03-29       Impact factor: 4.003

6.  Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance.

Authors:  Kangping Song; Xiuli Zeng; Xiaomei Xie; Rongxuan Zhu; Jianye Liang; Guobing Chen; Li'an Huang
Journal:  Stroke Vasc Neurol       Date:  2022-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.